142 related articles for article (PubMed ID: 9466525)
1. Investigational vaccine for Escherichia coli O157: phase 1 study of O157 O-specific polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugates in adults.
Konadu EY; Parke JC; Tran HT; Bryla DA; Robbins JB; Szu SC
J Infect Dis; 1998 Feb; 177(2):383-7. PubMed ID: 9466525
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children.
Ahmed A; Li J; Shiloach Y; Robbins JB; Szu SC
J Infect Dis; 2006 Feb; 193(4):515-21. PubMed ID: 16425130
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines.
Konadu E; Robbins JB; Shiloach J; Bryla DA; Szu SC
Infect Immun; 1994 Nov; 62(11):5048-54. PubMed ID: 7927787
[TBL] [Abstract][Full Text] [Related]
4. Clinical Studies of Escherichia coli O157:H7 Conjugate Vaccines in Adults and Young Children.
Szu SC; Ahmed A
Microbiol Spectr; 2014 Dec; 2(6):. PubMed ID: 26104443
[TBL] [Abstract][Full Text] [Related]
5. Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice.
Konadu E; Donohue-Rolfe A; Calderwood SB; Pozsgay V; Shiloach J; Robbins JB; Szu SC
Infect Immun; 1999 Nov; 67(11):6191-3. PubMed ID: 10531288
[TBL] [Abstract][Full Text] [Related]
6. Mucosal and systemic antibody responses to the lipopolysaccharide of Escherichia coli O157 in health and disease.
Currie CG; McCALLUM K; Poxton IR
J Med Microbiol; 2001 Apr; 50(4):345-354. PubMed ID: 11289520
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.
Kossaczka Z; Lin FY; Ho VA; Thuy NT; Van Bay P; Thanh TC; Khiem HB; Trach DD; Karpas A; Hunt S; Bryla DA; Schneerson R; Robbins JB; Szu SC
Infect Immun; 1999 Nov; 67(11):5806-10. PubMed ID: 10531232
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models.
van den Dobbelsteen GPJM; Faé KC; Serroyen J; van den Nieuwenhof IM; Braun M; Haeuptle MA; Sirena D; Schneider J; Alaimo C; Lipowsky G; Gambillara-Fonck V; Wacker M; Poolman JT
Vaccine; 2016 Jul; 34(35):4152-4160. PubMed ID: 27395567
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of a polyvalent Escherichia coli O-polysaccharide-toxin A conjugate vaccine.
Cryz SJ; Que JO; Cross AS; Fürer E
Vaccine; 1995 Apr; 13(5):449-53. PubMed ID: 7639013
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis.
Welch PG; Fattom A; Moore J; Schneerson R; Shiloach J; Bryla DA; Li X; Robbins JB
J Am Soc Nephrol; 1996 Feb; 7(2):247-53. PubMed ID: 8785394
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humans.
Cryz SJ; Cross AS; Sadoff JC; Wegmann A; Que JU; Fürer E
J Infect Dis; 1991 May; 163(5):1040-5. PubMed ID: 1708398
[TBL] [Abstract][Full Text] [Related]
12. First characterization of immunogenic conjugates of Vi negative Salmonella Typhi O-specific polysaccharides with rEPA protein for vaccine development.
Salman M; St Michael F; Ali A; Jabbar A; Cairns C; Hayes AC; Rahman M; Iqbal M; Haque A; Cox AD
J Immunol Methods; 2017 Nov; 450():27-33. PubMed ID: 28735760
[TBL] [Abstract][Full Text] [Related]
13. Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.
Cuccui J; Thomas RM; Moule MG; D'Elia RV; Laws TR; Mills DC; Williamson D; Atkins TP; Prior JL; Wren BW
Open Biol; 2013 May; 3(5):130002. PubMed ID: 23697804
[TBL] [Abstract][Full Text] [Related]
14. Preparation and immunogenicity-evaluation of typhoid O-specific polysaccharides bio-conjugate vaccines.
Peng ZH; Pan C; Sun P; Feng EL; Wu J; Zhu L; Peng QZ; Wang HL
Yi Chuan; 2015 May; 37(5):473-9. PubMed ID: 25998436
[TBL] [Abstract][Full Text] [Related]
15. Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections.
Tanomand A; Farajnia S; Najar Peerayeh S; Majidi J
Iran Biomed J; 2013; 17(1):1-7. PubMed ID: 23279828
[TBL] [Abstract][Full Text] [Related]
16. A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
Cryz SJ; Fürer E; Sadoff JC; Germanier R
Antibiot Chemother (1971); 1987; 39():249-55. PubMed ID: 3118786
[No Abstract] [Full Text] [Related]
17. Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.
Fattom A; Schneerson R; Watson DC; Karakawa WW; Fitzgerald D; Pastan I; Li X; Shiloach J; Bryla DA; Robbins JB
Infect Immun; 1993 Mar; 61(3):1023-32. PubMed ID: 8432585
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines.
Cryz SJ; Cross AS; Sadoff JC; Fürer E
Infect Immun; 1990 Feb; 58(2):373-7. PubMed ID: 2105272
[TBL] [Abstract][Full Text] [Related]
19. Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
Cryz SJ; Lang A; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Schaad U
Behring Inst Mitt; 1997 Feb; (98):345-9. PubMed ID: 9382759
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study.
Hatz CF; Bally B; Rohrer S; Steffen R; Kramme S; Siegrist CA; Wacker M; Alaimo C; Fonck VG
Vaccine; 2015 Aug; 33(36):4594-601. PubMed ID: 26162850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
